灵康药业
(603669)
| 流通市值：42.03亿 | | | 总市值：42.03亿 |
| 流通股本：7.12亿 | | | 总股本：7.12亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 257,457,947.37 | 86,535,882.34 | 322,483,887.6 | 281,860,683.71 |
| 营业总成本 | 231,452,857.77 | 83,969,840.24 | 490,562,003.63 | 328,175,187.22 |
| 其他经营收益 | | | | |
| 营业利润 | 21,846,985.71 | 3,551,240.57 | -195,973,853.02 | -37,302,707.07 |
| 利润总额 | 21,449,199.22 | 3,153,905.53 | -193,514,432.68 | -34,502,759.99 |
| 净利润 | 21,112,693.34 | 2,955,905.52 | -193,239,351.39 | -34,503,145.52 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 2,004,742.18 | - |
| 综合收益总额 | 21,112,693.34 | 2,955,905.52 | -191,234,609.21 | -34,503,145.52 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 557,025,793.63 | 541,975,785.92 | 525,378,956.51 | 575,271,011.14 |
| 非流动资产: | | | | |
| 非流动资产合计 | 567,010,962.85 | 579,696,599.09 | 581,400,511.1 | 625,959,236.96 |
| 资产总计 | 1,124,036,756.48 | 1,121,672,385.01 | 1,106,779,467.61 | 1,201,230,248.1 |
| 流动负债: | | | | |
| 流动负债合计 | 458,064,465.35 | 472,574,908.35 | 478,581,740.62 | 184,992,263.12 |
| 非流动负债: | | | | |
| 非流动负债合计 | 24,570,679.37 | 25,859,368.92 | 7,915,524.83 | 280,934,164.38 |
| 负债合计 | 482,635,144.72 | 498,434,277.27 | 486,497,265.45 | 465,926,427.5 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 641,401,611.76 | 623,238,107.74 | 620,282,202.16 | 735,303,820.6 |
| 股东权益合计 | 641,401,611.76 | 623,238,107.74 | 620,282,202.16 | 735,303,820.6 |
| 负债和股东权益合计 | 1,124,036,756.48 | 1,121,672,385.01 | 1,106,779,467.61 | 1,201,230,248.1 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 258,542,572.61 | 73,964,463 | 403,135,141.06 | 278,490,422.79 |
| 经营活动现金流出小计 | 272,743,969.26 | 103,198,162.1 | 536,000,226.82 | 396,543,055.7 |
| 经营活动产生的现金流量净额 | -14,201,396.65 | -29,233,699.1 | -132,865,085.76 | -118,052,632.91 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,100,000 | 100,000 | 35,145,107.46 | 37,594,107.27 |
| 投资活动现金流出小计 | 2,030,506.23 | 1,921,160 | 2,683,196.08 | 1,024,744.02 |
| 投资活动产生的现金流量净额 | 3,069,493.77 | -1,821,160 | 32,461,911.38 | 36,569,363.25 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 406,001,713.45 | 20,001,713.45 | 265,000,000 | 257,008,404.39 |
| 筹资活动现金流出小计 | 387,298,555.58 | 130,722.23 | 258,658,784.41 | 250,001,008.25 |
| 筹资活动产生的现金流量净额 | 18,703,157.87 | 19,870,991.22 | 6,341,215.59 | 7,007,396.14 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 7,571,254.99 | -11,183,867.88 | -94,061,958.79 | -74,475,873.52 |
| 期末现金及现金等价物余额 | 160,778,716.72 | 142,023,593.85 | 153,207,461.73 | 172,793,547 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 7,571,254.99 | - | -94,061,958.79 | - |